Tag: CAR T cells

Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors

KTE-X19 may induce remission in patients with relapsed or refractory B-cell lymphoblastic leukemia

byNeel Mistryand1 others

August 17, 2021

1. 71% patients achieved complete remission or complete remission with incomplete recovery following KTE-X19 infusion. 2. The majority of adverse ...

Allogeneic anti-CD19 T cell therapy shows a manageable safety profile in pediatric and adult patients with high risk B-cell acute lymphoblastic leukemia

byMichael Pratteand1 others

December 23, 2020

1. In two phase 1 studies, allogenic anti-CD19 CAR T cell (UCART19) treatment showed a manageable safety profile with relapsed ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result